Skip to main content
SpringerLink
Log in

Demonstration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathogenesis of thyroid-associated ophthalmopathy

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The thyrotropin (TSH) receptor is implicated in the pathogenesis of thyroid-associated ophthalmopathy, but its presence has not been demonstrated in orbital tissues. Binding of 125|-TSH to porcine orbital connective tissue and thyroid membranes was studied. At pH 7.4 125|-TSH bound to thyroid membranes with high affinity, but not to orbital connective tissue membranes. At pH 5.2, binding of 125|-TSH was evident on thyroid and orbital connective tissue membranes, although of low affinity. Low affinity binding at pH 5.2, could also be demonstrated on orbital fibroblasts; binding to membranes prepared from extraocular muscle, or from abdominal adipose tissue was not detected. Immunoglobulin G from healthy subjects (n=17) and patients with ophthalmopathy (n=19) were tested for inhibition of 125|-TSH binding to membranes. As anticipated patients’ IgG exhibited greater inhibition than normal controls with thyroid membranes at pH 7.4 (p<0.001). Similar results were obtained with thyroid membranes (p< 0.05), and orbital connective tissue membranes at pH 5.2 (p<0.001). Significant correlations were found when percentage inhibition by IgG was compared between: thyroid membranes at pH 7.4 and thyroid membranes at pH 5.2, orbital connective tissue membranes at pH 5.2 and thyroid membranes at pH 7.4, and orbital connective tissue membranes at pH 5.2 and thyroid membranes at pH 5.2. A low affinity TSH-binding site is present in orbital connective tissue, and is recognized by IgG’s from patients with ophthalmopathy which suggests that TSH receptor antibodies may target the orbit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Perros P., Kendall-Taylor P. Pathogenetic mechanisms in thyroid-associated ophthalmopathy. J. Intern. Med. 231: 205, 1992.

    Article  PubMed  CAS  Google Scholar 

  2. Kroll A.J., Kuwabara T. Dysthyroid ocular myopathy. Arch. Ophthalmol. 76: 244, 1966.

    Article  PubMed  CAS  Google Scholar 

  3. Hufnagel T.J., Hichey W.F., Cobbs N.H., Jacobiec F.A., Iwamoto T., Eagle R.C. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves’ disease. Ophthalmology 91: 1411, 1984.

    Article  PubMed  CAS  Google Scholar 

  4. Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves’ extraocular muscle. Invest. Ophthalmol. Vis. Sci. 29: 175, 1988.

    PubMed  CAS  Google Scholar 

  5. Bahn R.S., Heufelder A.E. Role of connective tissue autoimmunity in Graves’ ophthalmopathy. Autoimmunity 13: 75, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Kodama K., Bandy-Dafoe P., Sikorsa H., Bayly R., Wall J.R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet ii: 1353, 1982.

    Article  Google Scholar 

  7. Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves’ ophthalmopathy and its relation to retroorbital and thyroid autoimmunity. Br. Med. J. 288: 1183, 1984.

    Article  CAS  Google Scholar 

  8. Bahn R.S., Gorman C.A., Woloschak G.E., David C.S., Johnson P.M. Johnson C.M. Human retroocular fibroblast in vitro. A model for the study of Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 65: 665, 1987.

    Article  PubMed  CAS  Google Scholar 

  9. Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 232: 135, 1988.

    Article  PubMed  CAS  Google Scholar 

  10. Rotella C.M., Zonefrati R., Toccafondi R., Valente W.A., Kohn L.D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblast. An assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera. J. Clin. Endocrinol. Metab. 62: 357, 1986.

    CAS  Google Scholar 

  11. Tao T.-W., Leu S.-L., Kriss J.P. Biological activity of autoantibodies associated with Graves’ dermopathy. J. Clin. Endocrinol. Metab. 69: 90, 1989.

    Article  PubMed  CAS  Google Scholar 

  12. Davies T.F., Teng C.S., Mc.Lachlan S.M., Rees Smith B., Hall R. Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol. Cell. Endocrinol. 9: 301, 1978.

    Article  Google Scholar 

  13. Weetman A.P. Thyroid-associated eye disease: pathophysiology. Lancet 338: 25, 1991.

    Article  PubMed  CAS  Google Scholar 

  14. Werner S.C. Modification of the classification of the eye changes in Graves’ Disease; Recommendations of the ad hoc committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44: 203, 1977.

    Article  PubMed  CAS  Google Scholar 

  15. Atkinson S., Hardwick M., Kendall-Taylor P. Thyrotropin-blocking antibodies in goitrous primary hypothyroidism: detection by a highly sensitive bioassay and determination of site of action. J. Endocrinol. 118: 141, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Weightman D.R., Shale D.J., Tomlinson W.R. A rapid radioassay for human IgG produced in lymphocytes in vitro culture systems. J. Immunol. Methods 46: 307, 1981.

    Article  PubMed  CAS  Google Scholar 

  17. Rees Smith B., Pyle G.A., Petersen V.B., Hall R. Interaction of thyrotropin with the human thyrotrophin receptor. J. Endocrinol. 75: 391, 1977.

    Article  CAS  Google Scholar 

  18. Pekonen F., Weintraub B.D. Thyrotropin binding to cultured lymphocytes and thyroid cells. Endocrinology 103: 1668, 1978.

    Article  PubMed  CAS  Google Scholar 

  19. Winand R.J., Kohn LD. The binding of [3H] thyrotropin and an 3H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc. Natl. Acad. Sci. USA 69: 1711, 1972.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Gill D.L., Marshall N.J., Ekins R.P. Binding of thyrotropin to receptors in fat tissue. Mol. Cell. Endocrinol. 87: 33, 1978.

    Google Scholar 

  21. Trokoudes K.M., Michelson H., Kidd A., Row V.V., Volpe R. Properties of human thyroidal and extrathyroidal TSH receptors. Acta Endocrinol. (Copenh.) 97: 473, 1981.

    CAS  Google Scholar 

  22. Meek J.C., Kobayashi M., Waxman J.E. Radioreceptor assay for human thyrotropin (hTSH). Clin. Res. 22: 634A, 1974.

    Google Scholar 

  23. Pekonen F., Weintraub B.D. Thyrotropin receptors on bovine thyroid membranes: two types with different affinities and specificities. Endocrinology 105: 352, 1979.

    Article  PubMed  CAS  Google Scholar 

  24. Rees Smith B., McLachlan S.M., Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr. Rev. 9: 106, 1988.

    Article  PubMed  CAS  Google Scholar 

  25. Shewring G., Rees Smith B. An improved radioreceptor assay for TSH receptor antibodies. Clin. Endocrinol. (Oxf.) 17: 409, 1982.

    Article  CAS  Google Scholar 

  26. Yamamoto M., Rapaport B. Studies on the binding of radiolabeled thyrotropin to cultured human thyroid cells. Endocrinology 103: 2011, 1978.

    Article  PubMed  CAS  Google Scholar 

  27. Akamizu T., Saji M., Kohn L.D. A microsequencing approach to identify proteins which appear to interact with thyrotropin in rat FRTL-5 thyroid cels. Biochem. Biophys. Res. Commun. 170: 351, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Libert F., Lefort A., Gerand D., Parmantier M., Perret J., Ludgate M., Dumont J.E., Vassart G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun. 165: 1250, 1989.

    Article  PubMed  CAS  Google Scholar 

  29. Nagayama Y., Kaufman K.D., Seto P., Rappaport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 165: 1184; 1989.

    Article  PubMed  CAS  Google Scholar 

  30. Permantier M., Libert F., Maenhaut C., Lefort A., Gerard C., Perret. G.J., van Sande J., Dumond J.E., Vassart G. Molecular cloning of the thyrotropin receptor. Science 246: 1620, 1989.

    Article  Google Scholar 

  31. Feliciello A., Porcellini A., Ciullo I., Bonavolontà G., Avvedimento V.E., Fenzi G.F. Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue. Lancet 342: 337, 1993.

    Article  PubMed  CAS  Google Scholar 

  32. Francis T., Burch H.B., Cai W.-Y., Lukes Y., Peele M., Carr F.E., Wartofski L, Burman K.D. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1: 223, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK

    P. Perros & P. Kendall-Taylor

Authors
  1. P. Perros
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kendall-Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perros, P., Kendall-Taylor, P. Demonstration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol Invest 17, 163–170 (1994). https://doi.org/10.1007/BF03347708

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347708

Key-words

Search

Navigation